Biogen CEO scoops up $2.3M Back Bay condo
April 03, 2018 at 14:31 PM EDT
The Cambridge drug giant appointed Michel Vounatsos to replace longtime CEO George Scangos in January 2017.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|